A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease
With the aging of the population, the incidence of Alzheimer's disease (AD) has increased dramatically, causing severe medical, care, and economic burdens on society and families. The efficacy of rivastigmine hydrogen tartrate (RHT), the first-line clinical treatment, is severely limited by the...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2025-02-01
|
| Series: | Bioactive Materials |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X24004420 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846123319148937216 |
|---|---|
| author | Xiao Yue Haihua Guo Guanlin Wang Jieyun Li Zizhao Zhai Zeting Wang Wenhao Wang Ziyu Zhao Xiao Xia Chuangxin Chen Yingtong Cui Chuanbin Wu Zhengwei Huang Xuejuan Zhang |
| author_facet | Xiao Yue Haihua Guo Guanlin Wang Jieyun Li Zizhao Zhai Zeting Wang Wenhao Wang Ziyu Zhao Xiao Xia Chuangxin Chen Yingtong Cui Chuanbin Wu Zhengwei Huang Xuejuan Zhang |
| author_sort | Xiao Yue |
| collection | DOAJ |
| description | With the aging of the population, the incidence of Alzheimer's disease (AD) has increased dramatically, causing severe medical, care, and economic burdens on society and families. The efficacy of rivastigmine hydrogen tartrate (RHT), the first-line clinical treatment, is severely limited by the complex and multiple pathogenesis of AD and low brain bioavailability caused by the blood-brain barrier (BBB). Confronting such two bottlenecks, the development of multi-target agents encapsulated BBB-bypassing drug delivery systems offer tremendous therapeutics possibilities for AD. In this study, a tailored phytosomes based nose-to-brain drug delivery system with appropriate plume was successfully designed and developed. On the one hand, Ginseng RG3-based phytosomes loaded with RHT was designed for the co-delivery of GRg3 and RHT, achieving the multi-target pharmacology for AD treatment. On the other hand, a tailored nose-to-brain drug delivery system was established for the satisfactory nose-to-brain delivery efficiency, avoiding the obstacle of BBB through bypassing it. In the pharmacodynamic study based on AD rat model, GRg3@RHT exhibited obviously synergic effect, effectively break the vicious cycle of AD progression, ultimately markedly ameliorating learning and memory ability as well as behavioral dysfunctions, and delaying the neurodegenerative process associated with AD. In addition, the strong correlation of viscosity-droplet size-plume geometry-olfactory deposition was also established, and further proved by the in vivo pharmacokinetic study, which is proposed to provide evidence to enhance nose-to-brain delivery efficiency. This study is anticipated to provide novel insights into AD treatment strategies while offering innovative ideas for drug delivery approaches targeting nervous system disorders. |
| format | Article |
| id | doaj-art-217e6d1e96484ad4ad5ce3263cd3a895 |
| institution | Kabale University |
| issn | 2452-199X |
| language | English |
| publishDate | 2025-02-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Bioactive Materials |
| spelling | doaj-art-217e6d1e96484ad4ad5ce3263cd3a8952024-12-14T06:31:39ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2025-02-014497115A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's diseaseXiao Yue0Haihua Guo1Guanlin Wang2Jieyun Li3Zizhao Zhai4Zeting Wang5Wenhao Wang6Ziyu Zhao7Xiao Xia8Chuangxin Chen9Yingtong Cui10Chuanbin Wu11Zhengwei Huang12Xuejuan Zhang13State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, PR China; College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR ChinaKey Lab of Yuebei Food & Medicine Resources Utilization, Medical School, Shaoguan University, Shaoguan, 512005, PR ChinaSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, Guangdong, PR ChinaSchool of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, Guangdong, PR ChinaState Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, PR China; College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR ChinaState Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, PR China; College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR ChinaSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, Guangdong, PR China; Corresponding author. School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, Guangdong, PR China.State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, PR China; College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR ChinaState Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, PR China; College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR ChinaState Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, PR China; College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR ChinaSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, Guangdong, PR ChinaState Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, PR China; College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR ChinaState Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, PR China; College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR China; Corresponding author. College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR China.State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 510006, PR China; College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR China; Corresponding author. College of Pharmacy, Jinan University, Guangzhou, 510006, Guangdong, PR China.With the aging of the population, the incidence of Alzheimer's disease (AD) has increased dramatically, causing severe medical, care, and economic burdens on society and families. The efficacy of rivastigmine hydrogen tartrate (RHT), the first-line clinical treatment, is severely limited by the complex and multiple pathogenesis of AD and low brain bioavailability caused by the blood-brain barrier (BBB). Confronting such two bottlenecks, the development of multi-target agents encapsulated BBB-bypassing drug delivery systems offer tremendous therapeutics possibilities for AD. In this study, a tailored phytosomes based nose-to-brain drug delivery system with appropriate plume was successfully designed and developed. On the one hand, Ginseng RG3-based phytosomes loaded with RHT was designed for the co-delivery of GRg3 and RHT, achieving the multi-target pharmacology for AD treatment. On the other hand, a tailored nose-to-brain drug delivery system was established for the satisfactory nose-to-brain delivery efficiency, avoiding the obstacle of BBB through bypassing it. In the pharmacodynamic study based on AD rat model, GRg3@RHT exhibited obviously synergic effect, effectively break the vicious cycle of AD progression, ultimately markedly ameliorating learning and memory ability as well as behavioral dysfunctions, and delaying the neurodegenerative process associated with AD. In addition, the strong correlation of viscosity-droplet size-plume geometry-olfactory deposition was also established, and further proved by the in vivo pharmacokinetic study, which is proposed to provide evidence to enhance nose-to-brain delivery efficiency. This study is anticipated to provide novel insights into AD treatment strategies while offering innovative ideas for drug delivery approaches targeting nervous system disorders.http://www.sciencedirect.com/science/article/pii/S2452199X24004420Alzheimer's diseasePhytosomesGinseng RG3Nose-to-brain drug delivery systemMulti-target pharmacology |
| spellingShingle | Xiao Yue Haihua Guo Guanlin Wang Jieyun Li Zizhao Zhai Zeting Wang Wenhao Wang Ziyu Zhao Xiao Xia Chuangxin Chen Yingtong Cui Chuanbin Wu Zhengwei Huang Xuejuan Zhang A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease Bioactive Materials Alzheimer's disease Phytosomes Ginseng RG3 Nose-to-brain drug delivery system Multi-target pharmacology |
| title | A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease |
| title_full | A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease |
| title_fullStr | A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease |
| title_full_unstemmed | A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease |
| title_short | A tailored phytosomes based nose-to-brain drug delivery strategy: Silver bullet for Alzheimer's disease |
| title_sort | tailored phytosomes based nose to brain drug delivery strategy silver bullet for alzheimer s disease |
| topic | Alzheimer's disease Phytosomes Ginseng RG3 Nose-to-brain drug delivery system Multi-target pharmacology |
| url | http://www.sciencedirect.com/science/article/pii/S2452199X24004420 |
| work_keys_str_mv | AT xiaoyue atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT haihuaguo atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT guanlinwang atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT jieyunli atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT zizhaozhai atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT zetingwang atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT wenhaowang atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT ziyuzhao atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT xiaoxia atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT chuangxinchen atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT yingtongcui atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT chuanbinwu atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT zhengweihuang atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT xuejuanzhang atailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT xiaoyue tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT haihuaguo tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT guanlinwang tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT jieyunli tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT zizhaozhai tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT zetingwang tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT wenhaowang tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT ziyuzhao tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT xiaoxia tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT chuangxinchen tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT yingtongcui tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT chuanbinwu tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT zhengweihuang tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease AT xuejuanzhang tailoredphytosomesbasednosetobraindrugdeliverystrategysilverbulletforalzheimersdisease |